Home En Francais

BioVision TWAS Lilly Award

in conjunction with TWAS, the academy of sciences for the developing world

Recognising outstanding contributions to infectious disease research by young scientists from developing countries
 

Downloads

Summary
Nomination Form

BioVision and TWAS, the academy of sciences for the developing world, with the support of the Lilly MDR-TB Partnership, have established the BioVision Lilly Award for young scientists to honor outstanding scientific achievements made by individual young scientists from the developing countries.
The award ceremony will take place at the innovation Dinner on March 28th.

PURPOSE 

The prize has been established to recognize young scientists living and working in a developing country, who have a track record of excellent research in infectious diseases, with an emphasis on tuberculosis preferred, and whose research promises to have a positive impact in the developing world.
 

AWARDS 

In 2011, three winners will be selected from nominations received. No more than two winners will be selected from the same developing country. 

  • The winner receives a sum of US$5,000 to be used for his/her research and an invitation to attend BioVision 7th World Life Sciences Forum (Lyon, France, 27-29 March 2011) (travel and lodging costs covered).
  • The first runner-up receives a sum of US$2,000 to be used for his/her researc and an invitation to attend BioVision2011 (travel and lodging costs covered) as part of the "BioVision.Nxt" programme.
  • The second runner-up receives an invitation to attend BioVision2011 (travel and lodging costs covered) as part of the “BioVision.Nxt” programme.
  • Each prize also carries a certificate bearing a citation highlighting the major contributions for which the prize is awarded. 
  • The prizes will be presented to the recipients at a special ceremony arranged by BioVision, TWAS and Lilly during BioVision2011 in the presence of participants, speakers and the media.
     

ELIGIBILITY 

  • Candidates must be nationals of a developing country, and have been living and working in a developing country for at least the two years immediately prior to their nomination.
  • Candidates should be no older than forty years of age on December 31st  2011.
  • Candidates should hold at least a PhD degree and have a good record of research publications in internationally recognized journals.
  • Employees of TWAS, Eli Lilly & Company, BioVision as well as employees of other industry research laboratories and anyone involved in the administration of this award, are not eligible.
     

EVALUATION

  • Selection of the recipients is made on scientific merit based on the recommendations of an expert and international jury chaired by the TWAS President. 
     

NOMINATIONS 

  • Nominations are invited from TWAS members, as well as from science academies, national research councils, universities, scientific institutions and academics.
  • Nominations of women scientists are particularly encouraged.
  • Self-nomination or nomination by a member(s) of the jury for the “BioVision Lilly Award in conjunction with TWAS” are not accepted.
     

ENQUIRIES

Additional information and nomination forms are available from the TWAS Secretariat (biovisionprize@twas.org, www.twas.org).

Nominations for the 2011 prizes should be sent by regular mail or by email to:  

BioVision Lilly Award in conjunction with TWAS
c/o TWAS, the academy of sciences for the developing world
ICTP Campus
Strada Costiera 11
34151 Trieste
Italy

Tel: +39 040 2240387
Fax: +39 040 22407387
E-mail:biovisionprize@twas.org

DEADLINE

Downloads

Summary
Nomination Form

The deadline for receiving nominations for the BioVision TWAS Lilly Award for outstanding contributions in infectious disease research is January 15th 2011.  

Click here to download the nomination form

MORE INFORMATION

TWAS, the academy of sciences for the developing world – www.twas.org – is an autonomous international organization founded in Trieste, Italy in 1983.  TWAS represents the best of science in the developing world. Its principal aim is to promote scientific capacity and excellence for sustainable development in the South. The administration and financial operation of TWAS is undertaken by UNESCO in accordance with an agreement signed by the two organizations.

 

BioVision engages key international leaders from different backgrounds in debates on global issues involving science and society. Every other year in Lyon, BioVision brings together government and business leaders, scholars, policy makers and NGO directors. Participants analyze scientific breakthroughs, pressing global challenges, discuss the most effective solutions, and build lasting partnerships that enable them to create positive social change.

 

Recognizing that multidrug-resistant tuberculosis (MDR-TB) cannot be halted by medicine alone, Lilly created the Lilly MDR-TB Partnership in 2003. This public-private initiative mobilizes over 20 partners on five continents to tackle the scourge of TB and MDR-TB. Eli Lilly and Company is contributing US$ 120 million in cash, medicines, advocacy tools and technology to focus global resources on prevention, diagnosis and treatment of TB and MDR-TB. An additional US$ 15 million was given to the Lilly TB Drug Discovery Initiative; a nonprofit with the goal of accelerating the discovery of new drugs to treat TB by bringing together specialists from around the world. The company has made this investment to ensure that thousands of MDR-TB patients receive the care and medication they need to combat this disease. www.lillymdr-tb.com.